Saliva-based test for coronavirus gets emergency FDA approval

lg
Credit: Associated Press/Rick Bowmer

There are now more options for COVID-19 testing as the US Food and Drug Administration gave emergency use authorization on April 13 for a saliva-based test, providing an alternative to the swab testing currently performed.

Currently, testing for COVID-19 involves a healthcare professional inserting a swab into each nostril, one at a time, to the nasopharynx at the back of the nasal cavity, gently scraping the tissue to collect material, and sending off for analysis, according to UC Davis Health. This method is cumbersome as it needs to be done by a qualified worker wearing fresh gloves and other personal protective equipment (PPE), which are in short supply. Additionally, many areas are experiencing a lack of tests available or a large backlog of samples to process.

The collection of a saliva sample requires spitting into a tube, resulting in a much less invasive procedure without tying up large amounts of PPE. Per the Food and Drug Administration’s (FDA) instructions, the testing would still occur in a healthcare setting under the supervision of a qualified professional.

USA Today reports that the saliva tests could be given to patients as soon as April 15. Until further notice, the tests can only be administered by RUCDR in New Jersey.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-22-2026-09_19_55-PM
The challenge of responding to a measles outbreak in a vaccine-skeptical community
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy’s nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-19-at-4.32.55-PM
Treat measles with cod liver oil and vitamin A? RFK, Jr.’s recommendation has led to a surge in poisonings
Screenshot-2026-06-18-at-3.52.25-PM
‘Plasticity’: Can psilocybin support healthy aging by transforming the brains of older adults?
Screenshot-2026-06-22-at-1.42.53-PM
Viewpoint: The booming longevity anti-aging skin care hoax
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
c-cd-b-fb-b
Trump administration pushes to bring AI “doctors” into U.S. healthcare. The promise — and the risks.
ChatGPT-Image-Jun-21-2026-02_33_08-PM
Texas Air Force base flu outbreak soars to over 220 cases, and one soldier has died after Secretary Hegseth scrapped mandatory military flu shots 
screenshot pm
Which is better for building healthy farm soil? Organic offers no special edge.
ChatGPT-Image-Jun-9-2026-01_11_37-PM
Turmeric supplements: More risks than benefits
ChatGPT-Image-Jun-13-2026-11_51_39-AM
Viewpoint: COVID lab leak? Misguided backers of the lab leak theory refuse to give up
ChatGPT-Image-Jun-15-2026-11_51_00-AM-4
Viewpoint: As the International Association for Research on Cancer loses influence, activists and trial lawyers scramble to protect a lucrative playbook
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.